ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2527

Association Of Nail Dystrophy With Capillaroscopic Abnormalities, Anti-Endothelial Cell Antibody, Endothelin-1, Activity and Chronicity In Systemic Lupus Erythematosus

Violeta Higuera1, Luis M. Amezcua-Guerra2, Felipe Massó3, Mariana Patlan4, Hugo Montoya5, Araceli Paez4 and Luis H. Silveira6, 1Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico city, Mexico, 2Rheumatology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, 3Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, 4Immunology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico city, Mexico, 5Instituto Nacional de Cardiologia Ignacio Chavez, Mexico city, Mexico, 6Rheumatology, Instituto Nacional Cardiología Ignacio Chávez, Mexico City, Mexico

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Clinical, endothelial cells, nailfold capillaroscopy, systemic lupus erythematosus (SLE) and vasculogenesis

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus-Clinical Aspects III: Biomarkers, Quality of Life and Disease Indicators, Late Complications

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown etiology, characterized by a broad spectrum of clinical manifestations. There is a large variety of nail abnormalities described in SLE; these abnormalities were detected with a frequency of 25-31% in different series of patients with SLE. Although nail changes have been rarely considered a specific sign of the disease, they have been associated with an increased disease activity, higher incidence of Raynaud’s phenomenon and oral ulcerations. It has been postulated that vascular damage plays a crucial role in the pathogenesis of SLE, so many studies have focused on the role of angiogenesis activity markers and endothelial damage. We suggest that the nail dystrophy (ND) could be a reflection of the damage to the microvasculature in patients with SLE.

Objectives: To evaluate the possible association between nail dystrophy (ND) and disease activity, damage index, capillaroscopic abnormalities, autoantibody profile, and endothelial cell activation markers in systemic lupus erythematosus (SLE).

Methods:

Analytical and transversal study of SLE patients from a Rheumatology Clinic in a tertiary care hospital. The patients have been divided in two groups, one with, and the other without ND (control group). Clinical, demographic, activity, chronicity, serologic, nailfold capillaroscopy (NFC) characteristics, serum levels of anti-endothelial cell antibodies (AECA), and plasma levels of endothelin-1 (ET-1), were compared between groups.  Activity was determined by the SLEDAI-2K and damage by the SLICC/ACR Damage Index. The AECA and ET-1 were determined by an enzyme-linked immunosorbent assay (ELISA).

The probability of differences in the variables frequency distributions was determined by χ2 test, and the significance of the differences between the means was determined using Mann-Whitney test.  P-values less than 0.05 were considered statistically significant. The unpaired t-test was used to assess differences between SLE subgroups.

Results:

Sixty one patients were included; 50 (82%) were female. Thirty two (52.5%) patients showed ND and 29 did not (control group). The sex, mean age and disease duration were similar in both groups. A significant association of ND with an increased damage index was found (p=0.04). Cyclophosphamide was more used in the ND group (p=0.03). Onycholysis was the most frequently nail change, it was reported in 40% of the patients. NFC changes were detected in 43% of the ND patients and in 13% of the controls (p=0.02). The most frequent NFC finding in the ND group was elongated capillaries (40%). There was not an association of autoantibody profile, ET-1, and AECA with ND.

Conclusion:

ND is associated with a greater index of chronicity and with capillaroscopic abnormalities. This might suggest that ND is caused by microvascular damage.


Disclosure:

V. Higuera,
None;

L. M. Amezcua-Guerra,
None;

F. Massó,
None;

M. Patlan,
None;

H. Montoya,
None;

A. Paez,
None;

L. H. Silveira,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-nail-dystrophy-with-capillaroscopic-abnormalities-anti-endothelial-cell-antibody-endothelin-1-activity-and-chronicity-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology